β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features.
Saved in:
| Title: | β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features. |
|---|---|
| Authors: | Park, Soeun1,2,3 (AUTHOR), Park, Jung Min1,2,3 (AUTHOR), Park, Minsu1,2,3 (AUTHOR), Ko, Dongmi1,2,3 (AUTHOR), Kim, Seongjae1,2,3 (AUTHOR), Seo, Juyeon1,2,3 (AUTHOR), Nam, Kee Dal1,3 (AUTHOR), Jung, Eunsun1,3 (AUTHOR), Farrand, Lee4 (AUTHOR), Kim, Yoon-Jae1,2,3 (AUTHOR) natureyj@nate.com, Kim, Ji Young1,3 (AUTHOR) amaryllis1210@gmail.com, Seo, Jae Hong1,2,3 (AUTHOR) cancer@korea.ac.kr |
| Source: | Cancer Cell International. 9/20/2022, Vol. 22 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
